Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardiology
Biotech
Cadrenal launches strategic review for cardiology pipeline
The biotech’s board is weighing options that could include selling drug candidates, partnering with other companies or even pursuing a merger.
Darren Incorvaia
Oct 7, 2026 12:54pm
Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts
Sep 1, 2026 1:55pm
Rethinking heart attacks as the nervous system gone haywire
Jan 27, 2026 11:00am
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 10:05am
Cell lines could lead to new drugs for deadly heart condition
Jun 4, 2024 2:12pm
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
May 13, 2024 9:36am
